Form 4 Nutanix, Inc. For: Aug 26 Filed by: RAMASWAMI RAJIV
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Nutanix (NTNX) PT Raised to $75 at RBC Capital
August 29, 2024 7:10 AM EDTRBC Capital analyst Matthew Hedberg raised the price target on Nutanix (NASDAQ: NTNX) to $75.00 (from $70.00) while maintaining a Outperform rating.
The analyst comments "Despite uncertainty about the initial FY/25 guide, Nutanix delivered solid Q4 results with ACV and revenue ahead of... More
Nutanix (NTNX) PT Raised to $77 at Piper Sandler, 'Top Pick'
August 29, 2024 5:50 AM EDTPiper Sandler analyst James Fish raised the price target on Nutanix (NASDAQ: NTNX) to $77.00 (from $76.00) while maintaining a Overweight rating.
The analyst comments "As typical over the last few years, Nutanix's overly cautious FQ3 tone resulted in expectations being reset... More
Nutanix (NTNX) PT Raised to $75 at JPMorgan
August 29, 2024 5:39 AM EDTJPMorgan analyst Mark Murphy raised the price target on Nutanix (NASDAQ: NTNX) to $75.00 (from $65.00) while maintaining a Overweight rating.
The analyst comments "Nutanix reported a solid end to its fiscal year exceeding all key guided metrics, while forward looking metrics continued to exhibit robust growth. The strength in the quarter was evident in the 22% y/y ARR growth and 21% y/y ACV billings growth, with the later landing 13 points above consensus... More



